Bone Marrow-Derived Endothelial Progenitor Cells: A Promising Therapeutic Alternative for Corneal Endothelial Dysfunction

Publisher： Karger

E-ISSN： 1422-6421|193|4|253-263

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.193, Iss.4, 2010-10, pp. : 253-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Cell Therapy Using Bone Marrow-Derived Stem Cells/Endothelial Progenitor Cells to Accelerate Neovascularization in Healing of Experimental Ulcerative Colitis

By  

Current Pharmaceutical Design, Vol. 17, Iss. 16, 2011-06 ,pp. : 1643-1651

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approaches in Vascular Repair Induced by Adult Bone Marrow Cells and Circulating Progenitor Endothelial Cells

By  

Current Pharmaceutical Design, Vol. 13, Iss. 31, 2007-11 ,pp. : 3245-3251

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Bone Marrow-Derived Cells in Fibrosis

By  

Cells Tissues Organs, Vol. 188, Iss. 1-2, 2008-01 ,pp. : 178-188

Karger

Access to resources Recommend Favorite

Endothelial Progenitor Cells in Prehypertension

By  

Current Pharmaceutical Design, Vol. 17, Iss. 28, 2011-09 ,pp. : 3002-3019

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Rho Kinase Inhibitors in Corneal Endothelial Dysfunction

By  

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 660-666

Bentham Science Publishers

Access to resources Recommend Favorite